CLN5 and melanoma: On one hand, BMPs have demonstrated inhibitory effects on the proliferation of gastric cancer, breast cancer, and prostate cancer cells [42,43]; on the other hand, BMPs have been reported to enhance the motility and invasiveness of various cancer cell types, including breast cancer, prostate cancer, and malignant melanoma cells [44].